Background characteristics of the participants.
| Total | Men | Women | |
|---|---|---|---|
| Age, yrs | |||
| ≤ 39 | 45 | 14 | 31 |
| 40–49 | 149 | 44 | 105 |
| 50–59 | 316 | 107 | 209 |
| 60–69 | 482 | 157 | 325 |
| 70–79 | 539 | 220 | 319 |
| ≥ 80 | 159 | 54 | 105 |
| Total, n | 1690 | 596 | 1094 |
| Mean (SD) selected characteristics | |||
| Age, yrs | 65.2 (12.0) | 66.3 (11.7) | 64.7 (12.1) |
| Height, cm | 155.2 (9.3) | 163.4 (7.2) | 150.7 (6.9) |
| Weight, kg | 55.6 (10.8) | 62.2 (10.9) | 52.0 (8.8) |
| BMI, kg/m2 | 23.0 (3.4) | 23.2 (3.2) | 22.9 (3.5) |
| Systolic BP, mm Hg | 135.1 (20.7) | 137.9 (19.6) | 133.5 (21.1) |
| Diastolic BP, mm Hg | 74.2 (11.5) | 77.0 (11.6) | 72.7 (11.2) |
| Serum levels of HDL cholesterol, mg/dl | 60.8 (15.7) | 56.1 (15.8) | 63.4 (15.0) |
| Serum levels of HbA1c, % | 5.20 (0.74) | 5.23 (0.83) | 5.19 (0.68) |
| Prevalence of selected characteristics, % | |||
| Current smoking habit | 13.1 | 29.9 | 3.8 |
| Current alcohol consumption | 39.8 | 66.7 | 25.1 |
| Medication for hypertension | 32.3 | 29.5 | 33.9 |
| Medication for dyslipidemia | 6.5 | 3.0 | 8.5 |
| Medication for diabetes mellitus (including insulin injection) | 5.9 | 7.7 | 4.9 |
| Prevalence of each component of metabolic syndrome, % | |||
| Obesity | 25.3 | 26.7 | 24.6 |
| Hypertension | 69.7 | 74.8 | 66.9 |
| Dyslipidemia | 12.3 | 13.9 | 11.4 |
| Impaired glucose tolerance | 21.5 | 24.3 | 20.0 |
BMI: body mass index; BP: blood pressure; HDL: high-density lipoprotein; HbA1c: hemoglobin A1c.